Business news for the stock market
Leverkusen (pta051/30.09.2025/22:48) - "Reference document: Half-year financial report as of June 30, 2025 (German and English versions), published on September 30, 2025
Reason for correction:
Correction of contradictory information regarding the forecast due to typing errors
Affected text passages
Section "Outlook and Forecast" (German version): Table "Geänderte Prognose 2025" at the bottom of page 22 and the paragraph immediately below it
Section "Outlook and Forecast" (English version): Table "Revised forecast 2025" at the bottom of page 21 and the paragraph immediately below it
Corrected information (consistent with the forecast in the ad hoc announcement dated August 1, 2025)
EBITDA 2025: • Correct: EUR 1.5 to 3.5 million • Originally incorrectly stated: EUR 0.5 to 1.5 million
Cash and cash equivalents as of December 31, 2025: • Correct: EUR 1 to 3 million • Originally incorrectly stated: EUR 0.5 to 3 million
The corrected half-year financial report is available on the company's website.
The corresponding press release dated September 30, 2025, 00:18 a.m., which was equally incorrect, was corrected on September 30, 2025, 8:15 p.m.
The
Management Board"
(end)
emitter: Biofrontera AG
address: Hemmelrather Weg 201, 51377 Leverkusen
country: Germany
contact person: Investor Relations
phone: +49 (0) 214 87 63 20
e-mail: ir@biofrontera.com
website: www.biofrontera.com
ISIN(s): DE000A4BGGM7 (share)
stock exchanges: regulated market in Dusseldorf, Frankfurt; free market in Munich, free market in Stuttgart; open market in Berlin, Tradegate